ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

PetMed Express appoints Tamar Elkeles as independent director and compensation committee chair

PetMed Express (NASDAQ: PETS) named former Qualcomm executive Tamar Elkeles to its board, effective Sept. 17, as chair of the Compensation and Human Capital Committee.

PA
Priya Anand · Equities & Earnings Desk · 21 Sept 2026 · 15:00 · 1 min read
Share
PetMed Express appoints Tamar Elkeles as independent director and compensation committee chair

PetMed Express Inc. (NASDAQ: PETS), an online pet pharmacy headquartered in Delray Beach, Florida, announced the appointment of Tamar Elkeles as an independent director and chair of its Compensation and Human Capital Committee, effective Sept. 17.

Elkeles joins the board after a 23‑year tenure as Chief Learning & Talent Officer at Qualcomm, where she oversaw human‑capital strategy while the company’s revenue rose from $100 million to more than $25 billion and its employee base grew from 700 to 35,000.

She currently serves as senior advisor at East Wind Advisors, advisor at 444 Capital, venture partner at Emerge Capital, and sits on the boards of Brightline Interactive and Open Sesame.

The move is part of a board refresh led by incoming board chair Justin Mennen and follows the recent elevation of Jeff Willard to chief executive officer and president, succeeding interim CEO Leslie C.G. Campbell, who also chaired the board.

Elkeles said she was “honored to join the PetMeds Board of Directors at such a pivotal inflection point for the business.”

Founded in 1996, PetMed Express operates a licensed online pharmacy in all 50 states, offering pet pharmaceuticals, compounded medications and supplements through the PetMeds family of brands and its PetCareRx subsidiary.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
ADVERTISEMENT